• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米载体介导活性氧(ROS)与线粒体钙超载之间的相互连锁促进作用,以增强抗肿瘤治疗效果。

Nano-carriers mediate reciprocally chained promotion between ROS and mitochondrial calcium overload for enhanced antitumor therapy.

作者信息

Zhao Zhihao, Ling Ke, Yan Jun, Wang Zhexiang, Chen Chuntao, Sun Dongping, Liu Jian

机构信息

Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Institute of Functional Nano and Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu Province 215123, China.

Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Institute of Functional Nano and Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu Province 215123, China.

出版信息

Acta Biomater. 2025 Jul 1;201:545-558. doi: 10.1016/j.actbio.2025.06.009. Epub 2025 Jun 16.

DOI:10.1016/j.actbio.2025.06.009
PMID:40516840
Abstract

Calcium ions (Ca²⁺) and reactive oxygen species (ROS) play pivotal roles in cellular signaling and the regulation of diverse biological processes. Complex and dynamic interactions between Ca²⁺ and ROS signaling pathways are often exploited by tumor cells to resist therapeutic interventions. In this study, we present a strategy of cancer treatment based on the reciprocally reinforcing interplay between ROS burst and mitochondrial calcium overload. The major components of our nano carriers integrate CaCO nanoparticles loaded with glucose oxidase (GOx), and copper peroxide nanodots (CPDs) in a DSPE-S-S-PEG-modified liposomal format (abbr. GCCL,). This hybrid nanosystem is designed to facilitate controlled and accelerated release of Ca²⁺ and ROS, thereby establishing dual positive feedback loops that amplify both mitochondrial calcium accumulation and oxidative stress. By harnessing this synergistic cycle, our platform enhances the efficacy of chemodynamic therapy and calcium-induced mitochondrial damage, offering a promising strategy for translational cancer treatment. STATEMENT OF SIGNIFICANCE: Here we report a strategy of antitumor therapeutic by designing a dual positive feedback loop of pH-driven self-accelerated Ca and HO release, thus reciprocally promoting ROS production and mitochondrial calcium overload for tumor eradication. After cellular uptake of GCCL, releasing of the cargos inside the liposomes can introduce a cascade of chemical reactions and biochemical cues, leading to calcium overload and ROS burst. These two major effects are mutually linked with each other, which is utilized by our GCCL design to fuel the positive feedback loops for tumor cell apoptosis in vitro and effective cancer ablation in vivo. Our nano therapy stands out with improved tumor suppression, with a lower dosage of copper element in the treatments of 4T1 xenograft tumor-bearing BALB/c mice model.

摘要

钙离子(Ca²⁺)和活性氧(ROS)在细胞信号传导及多种生物过程的调节中发挥着关键作用。肿瘤细胞常常利用Ca²⁺与ROS信号通路之间复杂而动态的相互作用来抵抗治疗干预。在本研究中,我们提出了一种基于ROS爆发与线粒体钙超载之间相互增强作用的癌症治疗策略。我们纳米载体的主要成分将负载葡萄糖氧化酶(GOx)的碳酸钙纳米颗粒和过氧化铜纳米点(CPD)整合到DSPE-S-S-PEG修饰的脂质体形式中(简称GCCL)。这种混合纳米系统旨在促进Ca²⁺和ROS的可控加速释放,从而建立双重正反馈回路,放大线粒体钙积累和氧化应激。通过利用这种协同循环,我们的平台提高了化学动力疗法和钙诱导的线粒体损伤的疗效,为转化癌症治疗提供了一种有前景的策略。重要性声明:在此我们报告一种抗肿瘤治疗策略,通过设计pH驱动的自加速Ca和HO释放的双重正反馈回路,从而相互促进ROS产生和线粒体钙超载以根除肿瘤。GCCL被细胞摄取后,脂质体内货物的释放可引发一系列化学反应和生化信号,导致钙超载和ROS爆发。这两种主要效应相互关联,我们的GCCL设计利用这一点来推动正反馈回路,以实现体外肿瘤细胞凋亡和体内有效癌症消融。我们的纳米疗法在肿瘤抑制方面表现突出,在4T1异种移植荷瘤BALB/c小鼠模型的治疗中使用较低剂量的铜元素。

相似文献

1
Nano-carriers mediate reciprocally chained promotion between ROS and mitochondrial calcium overload for enhanced antitumor therapy.纳米载体介导活性氧(ROS)与线粒体钙超载之间的相互连锁促进作用,以增强抗肿瘤治疗效果。
Acta Biomater. 2025 Jul 1;201:545-558. doi: 10.1016/j.actbio.2025.06.009. Epub 2025 Jun 16.
2
Construction of Z-Scheme MOF-on-MOF heterostructures for mitochondria-targeted sonodynamic therapy.用于线粒体靶向声动力治疗的Z型MOF-on-MOF异质结构的构建
Acta Biomater. 2025 May 1. doi: 10.1016/j.actbio.2025.05.001.
3
Macrophage Membrane-Coated Liposomes Delivering Vonoprazan Disrupt Mitochondrial Oxidative Phosphorylation in Diffuse Large B-Cell Lymphoma.巨噬细胞膜包被的递送沃克帕唑的脂质体破坏弥漫性大B细胞淋巴瘤中的线粒体氧化磷酸化。
Int J Nanomedicine. 2025 Jun 24;20:8063-8083. doi: 10.2147/IJN.S520567. eCollection 2025.
4
Nanocatalyst with Self-Strengthening Cascade Reaction for Enhanced Cancer Therapy.具有自增强级联反应的纳米催化剂用于增强癌症治疗
ACS Appl Mater Interfaces. 2025 Jul 9;17(27):39461-39472. doi: 10.1021/acsami.5c08291. Epub 2025 Jun 27.
5
Self-propelled smart nanomotors for enhanced mild photothermal therapy of tumors through autophagy modulation.通过自噬调节增强肿瘤温和光热疗法的自驱动智能纳米马达
Acta Biomater. 2025 Jul 1;201:574-590. doi: 10.1016/j.actbio.2025.05.063. Epub 2025 Jun 4.
6
ATP-responsive nanoparticles for improved chemodynamic therapy and dual starvation therapy.用于改善化学动力学疗法和双重饥饿疗法的ATP响应性纳米颗粒。
Nanoscale. 2025 Jul 3;17(26):15804-15814. doi: 10.1039/d5nr02053k.
7
The P2X7-Mediated Mitochondrial ROS as an Emerging Core Target of Tuftsin Nanoparticles in Severe Acute Pancreatitis Therapy via Regulating Mitophagy.P2X7介导的线粒体活性氧作为tuftsin纳米颗粒在重症急性胰腺炎治疗中通过调节线粒体自噬的新兴核心靶点。
ACS Appl Mater Interfaces. 2025 Feb 5;17(5):7521-7538. doi: 10.1021/acsami.4c21010. Epub 2025 Jan 24.
8
Ginsenoside F2-modified liposomes delivering FTY720 enhance glioblastoma targeting and antitumor activity via ferroptosis.递送FTY720的人参皂苷F2修饰脂质体通过铁死亡增强胶质母细胞瘤靶向性和抗肿瘤活性。
Phytomedicine. 2025 Aug;144:156917. doi: 10.1016/j.phymed.2025.156917. Epub 2025 May 30.
9
Multi-Focused Acoustic Radiation Force Impulse Modulation of Murine Hepatic Xenografts Enhances Nanoscale DOX@Lip Delivery and Therapeutic Effect.小鼠肝异种移植瘤的多聚焦声辐射力脉冲调制增强纳米级阿霉素脂质体递送及治疗效果
Int J Nanomedicine. 2025 Jun 12;20:7359-7373. doi: 10.2147/IJN.S522247. eCollection 2025.
10
A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity.一种具有解偶联特性的新型线粒体呼吸复合物 I 抑制剂具有强大的抗肿瘤活性。
Cell Death Dis. 2024 May 2;15(5):311. doi: 10.1038/s41419-024-06668-9.